Compound ID | 642

Update compound information

PA-1343

Class: Protein synthesis inhibitor

Spectrum of activity: Gram-positive
Details of activity: Active against Mycobacterium tuberculosis
Institute where first reported: Pathogenesis Corp. (Chiron Corp., USA)
Year first mentioned: 1997
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 402.28
Iso. SMILES: C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])NC(=O)OCC3=CC=C(C=C3)OC(F)(F)F
InChI Key: CNSIELLVDSSIAM-JTQLQIEISA-N
Can. SMILES: C1=C(C=CC(=C1)OC(F)(F)F)COC(=O)N[C@H]2CN3C=C(N=C3OC2)[N+](=O)[O-]
InChI: InChI=1S/C15H13F3N4O6/c16-15(17,18)28-11-3-1-9(2-4-11)7-27-14(23)19-10-5-21-6-12(22(24)25)20-13(21)26-8-10/h1-4,6,10H,5,7-8H2,(H,19,23)/t10-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/476520
Citations:
  • http://cdrwww.who.int/tdr/publications/documents/anti-tb-drug.pdf

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.